Key result
Statin withdrawal increases postprandial triglycerides by ~94% compared with continued therapy.
RCT (n=10)
Placebo-controlled
Randomized crossover order across 4 occasions
Answers are grounded in this paper and cite their sources.
Aims To determine the effects of statins on postprandial lipaemia (PPL) and to study if exercise could enhance statin actions. Methods Ten hypercholesteraemic (blood cholesterol 204 ± 36 mg dL −1 ; low‐density lipoprotein–cholesterol 129 ± 32 36 mg dL −1 ) overweight (body mass index 30 ± 4 kg m −2 ), metabolic syndrome individuals chronically medicated with statins (>6 months) underwent 5‐hour PPL tests in 4 occasions in a randomized order: (i) substituting their habitual statin medication by placebo for 96 hours (PLAC trial); (ii) taking their habitual statin medicine (STA trial); (iii) placebo combined with a bout of intense aerobic exercise (EXER+PLAC trial); and (iv) combining exercise and statin medicine (EXER+STA trial). Results Before the fat meal, statin withdrawal (i.e. PLAC and EXER+PLAC) increased blood triglycerides (TG; 24%), low‐density lipoprotein–cholesterol (31%) and total cholesterol (19%; all P < .05) evidencing treatment compliance. After the meal, statin withdrawal increased 5‐hour postprandial TG (PPTG) compared to its matched trials (94% higher PLAC vs STA and 45% higher EXER+PLAC vs EXER+STA; P < .05). EXER+PLAC trial did not lower PPTG below PLAC (i.e. incremental AUC of 609 ± 152 vs 826 ± 190 mg dL −1 5 h; P = .09). Adding exercise to statin did not result in larger reductions in PPTG (i.e. EXER+STA vs STA incremental area under the curve of 421 ± 87 vs 421 ± 84 mg dL −1 5 h; P = .99). Conclusion In hypercholesteraemic metabolic syndrome individuals, chronic statin therapy blunts the elevations in TG after a fat meal (i.e. incremental area under the curve of PPTG) reducing the cardiovascular risk associated to their atherogenic dyslipidaemia. However, a single bout of intense aerobic exercise before the high fat meal, does not reduce PPTG but also does not interfere with the effects of statin treatment.
No takes yet. Share an insight, caveat, or question.
Mora‐Rodríguez et al. (2020) conducted an RCT in Hypercholesterolaemia and metabolic syndrome in overweight individuals (n=10). Habitual statin therapy with or without a bout of intense aerobic exercise vs. Placebo substitution for 96 hours with or without intense aerobic exercise was evaluated on 5-hour postprandial triglycerides (PPTG) incremental area under the curve (p=<0.05). Statin withdrawal increased 5-hour postprandial triglycerides by 94% vs continued statins, while adding intense aerobic exercise to statins gave no further reduction.
Synapse has enriched 10 related papers. Consider them for comparative context: